Q32 Bio has stopped a Phase II trial of its former lead renal disease candidate as it focuses on its alopecia areata ...

As we begin 2025, I wanted to take the opportunity to recap on the progress we made in 2024 and key upcoming catalysts including our planned entrance into the multi-billion dollar U.S. market. 2024 ...

Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without ...

Qlaris Bio has reported positive topline outcomes from two Phase II US trials of QLS 111 in individuals with POAG and OHT.

South Korea's bioimpedance sensor market thrives on government funding, technological innovation, wearable integration, and ...

Beyond Cancer: Building Bridges Experts from Duke Cancer Institute discuss the creation of individualized management plans to transition patients from oncologist to primary care physician.

BIO SOLEA 2 is a 2 channel coagulometer which is simple and automatic. It works with any standard pipette. Automatic incubation occurs after the insertion of samples cups and automatically starts ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...